Frequency of polymorphisms pro198leu in GPX-1 gene and ile58thr in MnSOD gene in the altitude ecuadorian population with bladder cancer

Oncology Research

Volumn 18, Issue 8, 2010, Pages 395-400

  Paz y Miño, César ^a   Muñoz, María José ^a,b   López Cortés, Andrés ^a   Cabrera, Alejandro ^a   Palacios, Adriana ^a   Castro, Bernardo ^a   Paz y Miño, Nelson ^c   Sánchez, María Eugenia ^a  

^a UNIVERSIDAD DE LAS AMÉRICAS   (Ecuador)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

^c HOSPITAL CARLOS ANDRADE MARÍN   (Ecuador)

Author keywords

Bladder cancer; GPX 1; Ile58thr; MnSOD; Pro198leu

Indexed keywords

GLUTATHIONE PEROXIDASE 1; ISOLEUCINE; LEUCINE; MANGANESE SUPEROXIDE DISMUTASE; PROLINE;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; DETOXIFICATION; DNA POLYMORPHISM; ECUADOR; FEMALE; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT;

EID: 77950624389     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504010X12644422320780     Document Type: Article

References (24)

1. Wu, X.; Lin, X.; Dinney, C.; Gu, J.; Grossman, B. Genetic polymorphism in bladder cancer. FBS 12:192-213; 2007.
2. Leo Pasbos, C.; Botteman, M. F.; Laskin, B. L.; Redaelli, A. Bladder cancer: Epidemiology, diagnosis, and management. Cancer Pract. 10(6):311-322; 2002.
3. Ferlay, J.; Randi, G.; Bosetti, C.; et al. Declining mortality from bladder cancer in Europe. Urol. Oncol. 101:11-19; 2007.
4. Anuario de estadísticas vitales: Nacimientos y defunci-ones. Ecuador: Instituto Nacional de Estadísticas y Cen-sos; 2005.
5. Corral, F.; Cueva, P.; Yépez, J. Cancer epidemiology in Quito and other Ecuadorian regions. Quito: National Cancer Registry (NCR), SOLCA; 2004.
6. Macvicar, A. D. Bladder cancer staging. BJU Int. 86(1): 111-112; 2000.
7. Ichimura, Y.; Habuchi, T.; Tsuchiya, N.; et al. Increased risk of bladder cancer associated with a glutathione perox-idase 1 codon 198 variant. J. Urol. 172:728-732; 2004.
8. Atanasova, S.; Von Ahsen, N.; Schlumbohm, C.; Wieland, E.; Oellerich, M.; Armstrong, V. Marmoset glutathione peroxidases: cDNA sequences, molecular evolution, andAlaboratorymanual,2nd gene expression. J. Med. Primat. 35:155-164; 2006.
9. Arsova, Z.; Matevska, N.; Eken, A.; Petrovski, D.; Banev, S.; Dzikova, S.; Georgiev, V.; Sikole, A.; Erdem, O.; Sayal, A.; Aydin, A.; Dimovski, J. Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPX activity, and prostate cancer risk. Int. Urol. Nephrol. 41:63-70; 2008.
10. De Hann, J. B.; Bladier, C.; Griffiths, P.; et al. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased suceptibility to the oxidative stress-inducing agents parraquat and hydrogen peroxide. J. Biol. Chem. 273(35):22528-22536; 1998.
11. Clemente, C.; Elba, S.; Buongiorno, G.; et al. Manganese superoxide dismutase activity and incidence of hepatocel-lular carcinoma in patients with Child-Pugh class. A liver cirrhosis: A 7-year follow-up study. Liver Int. 27:791-797; 2007.
12. Borgstahl, G. E.; Parge, H. E.; Hickey, M. J.; et al. Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry 35:4287-4297; 1996.
13. Paz-y-Miño, C.; Arévalo, M.; Sánchez, M. E.; Leone, P. E. Chromosome and DNA damage analysis in individuals occupationally exposed to pesticides with relation to genetic polymorphism for CYP 1A1 gene in Ecuador. Mutat. Res. 562:77-89; 2004.
14. Paz-y-Miño, C.; Burgos, R.; Morillo, S.; Santos, J. C.; Fiallo, F.; Leone, P. E. BCR-ABL rearrangement frequencies in CML and ALL in Ecuador, South America. Cancer Genet. Cytogenet. 132:65-67; 1998.
15. Paz-y-Miño, C.; Leone, P. E. Three novel somatic mutations in the NF2 tumor suppressor gene (g816T>A; g1159A>G; gIVS11-1G>T). Hum. Mutat. 15(5):487; 2000.
16. Paz-y-Miño, C.; Pérez, J. C.; Burgos, R.; Dávalos, M. V.; Leone, P. E. The ?F508 mutation in Ecuador, South America. Hum. Mutat. 14:348-350; 1999.
17. Paz-y-Miño, C.; Pérez, J. C.; Fiallo, B. F.; Leone, P. E. A polymorphism in the hMSH2 gene (gIVS12-6T>C) associated with non-Hodgkin lymphomas. Cancer Genet. Cytogenet. 133:29-33; 2001.
18. Paz-y-Miño, C.; Witte, T.; Robles, P.; Llumipanta, W.; Díaz, M.; Arévalo, M. Association among polymorphisms in the steroid 5a-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population. Cancer Genet. Cytogenet. 189:71-76; 2009.
19. Sambrook, J.; Fritsch, E.; Maniatis, T. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
20. Ratnasinghe, D.; Tangrea, J. A.; Andersen, M. R.; et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res. 60:6381-6383; 2000.
21. Hu, Y. J.; Diamond, A. M. Role of glutathione peroxidase 1 in breast cancer: Loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 63: 3347-3351; 2003.
22. Mak, J. C.; Leung, H. C.; Ho, S. P.; Kow, F. W.; Cheung, A. H.; Chan-Yeung, M. M. Polymorphisms in manganese superoxide dismutase and catalase genes: Functional study in Hong Kong Chinese asthma patients. Clin. Exp. Allergy 36:440-447; 2006.
23. Hori, H.; Ohmori, O.; Shinkai, T.; et al. Manganese superoxide dismutase gene polymorphism and schizophrenia: Relation to tardive dyskinesia. Neuropsychopharmacology 23:170-177; 2000.
24. Ambrosone, C. B.; Freudenheim, J. L.; Thompson, P. A.; et al. Manganeso superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants and risk of breast cancer. Cancer Res. 59:602-606; 1999.